NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
NGM
Delisted
NGM was delisted on the 4th of April, 2024.
123 hedge funds and large institutions have $607M invested in NGM Biopharmaceuticals, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 50 increasing their positions, 28 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
17% less capital invested
Capital invested by funds: $730M → $607M (-$122M)
Holders
123
Holding in Top 10
7
Calls
$2.08M
Puts
–
Top Buyers
| 1 | +$24.2M | |
| 2 | +$13.2M | |
| 3 | +$10.2M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$10.1M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.98M |
Top Sellers
| 1 | -$57.4M | |
| 2 | -$24.2M | |
| 3 | -$14.6M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$5.37M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$4.32M |